`

Aeglea BioTherapeutics

Biotechnology Research

Specialities :
Biotech
Biotechnology
Rare disease
Human enzymes
And engineering enzymes
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$210.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Aeglea BioTherapeutics

What does Aeglea biotherapeutics do?+

With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. For more information, please visit http://aeglea.com

What are Aeglea biotherapeutics's specialties? +

Biotech,biotechnology,rare disease,human enzymes,and engineering enzymes

What is Aeglea biotherapeutics's industry? +

Aeglea biotherapeutics operates in the Biotechnology research industry.

What is Aeglea biotherapeutics's revenue? +

Aeglea biotherapeutics's revenue is 11m - 100m

What is Aeglea biotherapeutics's company size? +

Aeglea biotherapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free